Safety of recombinant interferon alpha 2b plus ribavirin in chronic hepatitis C

Article Spanish OPEN
Sánchez Rodríguez, Yoan Antonio; Arús Soler, Enrique; López Saura, Pedro; Nodarse Cuní, Hugo;
(2011)
  • Publisher: Editorial Ciencias Médicas
  • Subject: Hepatitis crónica C | ribavirin | interferón alfa 2b | síndrome seudogripal | Chronic hepatitis C | interferon alpha 2b | ribavirina | pseudocold syndrome | anemia

INTRODUCCIÓN: la hepatitis crónica C ha adquirido rango de pandemia. El virus de la hepatitis C se ha convertido en la causa principal de hepatitis crónica, cirrosis hepática, hepatocarcinoma, y trasplante de hígado a nivel mundial. OBJETIVO: identificar los efectos adv... View more
  • References (27)
    27 references, page 1 of 3

    1. Moreno OR, Diago M. Situaciones clínicas en el manejo de las hepatitis virales. Madrid: Grupo Acción Médica; 2005. p .3-207.

    2. Common Toxicity Criteria, version 2. Bethestda, Md: National Cancer Institute. 1999. Accessed Dec 15 2004. Available from http://ctep.info.nih.gov

    3. Gervais A, Boyer N, Marcellin P. Tolerability of treatments for viral hepatitis. Drug Saf. 2001;24(5):375-84.

    4. Davis GL, Esteban-Mur R, Rustgi V. Interferon alpha-2b alone in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med. 1998;339:1493-9.

    5. Dieperink E, Willenbring M, Ho S. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review. Am J Psych. 2000;157(6):867-76.

    6. Malaguarnera M, Di Fazio I, Restuccia S. Interferon alpha-induced depression in chronic hepatitis C patients:comparison between different types of interferon alpha. Neuropsychobiology. 1998;37:93-97.

    7. Nesic Z, Delic D, Prostran M. Psychiatric adverse effects induced by recombinant interferon alpha in patients with chronic hepatitis C. Med Pregl. 2004 MayJun;57(5-6):219-26.

    8. Pawlotsky JM, Dahari H, Neumann AU. Antiviral action of ribavirin in chronic hepatitis C. Gastroenterology. 2004 Mar;126(3):703-14.

    9. De Franceschi L, Fattovich G, Turrini F. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection : role of membrane oxidative damage. Hepatology. 2000;31:997-1004.

    10. Soza A, Everhart JE, Ghany MG. Neutropenia during combination therapy of interferon alpha and ribavirin for chronic hepatitis C. Hepatology. 2002;36:1273-9.

  • Similar Research Results (1)
  • Metrics
    No metrics available
Share - Bookmark